ATE368743T1 - Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden - Google Patents

Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden

Info

Publication number
ATE368743T1
ATE368743T1 AT00940557T AT00940557T ATE368743T1 AT E368743 T1 ATE368743 T1 AT E368743T1 AT 00940557 T AT00940557 T AT 00940557T AT 00940557 T AT00940557 T AT 00940557T AT E368743 T1 ATE368743 T1 AT E368743T1
Authority
AT
Austria
Prior art keywords
sequences encoding
constructs
dna
host cells
gene
Prior art date
Application number
AT00940557T
Other languages
English (en)
Inventor
David Anderson
Lin Liu
Sergey Podkovyrov
Baomin Wang
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/345,492 external-priority patent/US20020128457A1/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE368743T1 publication Critical patent/ATE368743T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/385—Pyrimidine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00940557T 1999-07-01 2000-06-30 Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden ATE368743T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14182799P 1999-07-01 1999-07-01
US09/345,492 US20020128457A1 (en) 1999-07-01 1999-07-01 Vectors, cells and processes for pyrimidine deoxyribonucleosides production

Publications (1)

Publication Number Publication Date
ATE368743T1 true ATE368743T1 (de) 2007-08-15

Family

ID=26839484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940557T ATE368743T1 (de) 1999-07-01 2000-06-30 Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden

Country Status (13)

Country Link
US (2) US6777209B1 (de)
EP (1) EP1190064B1 (de)
JP (1) JP2003504029A (de)
KR (1) KR20020019938A (de)
AT (1) ATE368743T1 (de)
AU (1) AU5547700A (de)
CZ (1) CZ301565B6 (de)
DE (1) DE60035781T2 (de)
ES (1) ES2290041T3 (de)
IL (1) IL147225A0 (de)
MX (1) MXPA02000134A (de)
NO (1) NO20016270L (de)
WO (1) WO2001002580A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7723097B2 (en) * 2005-03-11 2010-05-25 Archer-Daniels-Midland Company Escherichia coli strains that over-produce L-threonine and processes for their production
GB0602339D0 (en) * 2006-02-06 2006-03-15 Glaxo Group Ltd Novel process
JP2012125197A (ja) * 2010-12-16 2012-07-05 Kyowa Hakko Kirin Co Ltd タンパク質の生産方法
CN111748537B (zh) * 2020-08-04 2021-11-26 浙江华睿生物技术有限公司 一种尿苷磷酸酶突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH022349A (ja) * 1988-02-17 1990-01-08 Takeda Chem Ind Ltd ピリミジンアナログ耐性化遺伝子ｄｎａおよびその用途
ATE108487T1 (de) * 1988-05-31 1994-07-15 Zeneca Ltd Herstellung eines desoxyribonucleosids.
US5213972A (en) * 1989-12-08 1993-05-25 Chemgen Corporation Fermentation process for the production of pyrimidine deoxyribonucleosides

Also Published As

Publication number Publication date
KR20020019938A (ko) 2002-03-13
NO20016270D0 (no) 2001-12-20
EP1190064B1 (de) 2007-08-01
JP2003504029A (ja) 2003-02-04
DE60035781D1 (de) 2007-09-13
US7387893B2 (en) 2008-06-17
DE60035781T2 (de) 2008-08-07
US20050009083A1 (en) 2005-01-13
AU5547700A (en) 2001-01-22
EP1190064A1 (de) 2002-03-27
US6777209B1 (en) 2004-08-17
CZ301565B6 (cs) 2010-04-14
CZ20014695A3 (cs) 2002-04-17
MXPA02000134A (es) 2002-07-30
ES2290041T3 (es) 2008-02-16
WO2001002580A1 (en) 2001-01-11
NO20016270L (no) 2002-02-21
IL147225A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
IN2014DN02483A (de)
AU2003234196A1 (en) Functionalized nanoparticles and methods of use
PL372107A1 (en) Over-expression of extremozyme genes in pseudomonads and closely related bacteria
WO2003046173A1 (fr) Systeme d'expression d'arn si et procede de production de cellules d'inactivation de genes fonctionnelles et analogues au moyen de ce systeme
EP2267139A3 (de) Verfahren und Mittel zum Erhalt von modifizierten Phänotypen
WO2006012221A3 (en) Target cell-specific short interfering rna and methods of use thereof
AU6857696A (en) Methods for enhancing the production of interferon in cell culture
WO2004099387A3 (en) siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS
WO2005014796A3 (en) Methods and compositions for seamless cloning of nucleic acid molecules
WO2008020333A3 (en) Nucleic acid encoding n-methylputrescine oxidase and uses thereof
WO2003008575A3 (en) Dna sequences for regulating transcription
EP1841871A4 (de) Neuer l-lysin-induzierbarer promotor
WO2003006613A3 (en) Methods for ex vivo propagation of somatic stem cells
WO2001057058A3 (de) Nachweis von differenzieller genexpression
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
WO2003104470A3 (en) LET US RETURN FOR GENE TARGETING
ATE368743T1 (de) Vektoren, zellen und verfahren zur herstellung von pyrimidindeoxyribonucleosiden
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
AU2003260200A1 (en) Reversible, parallel and multitask cloning method and kit
WO2007039465A3 (en) Tetrahymena bifunctional dihydrofolate reductase - thymidylate synthase deficiency and its use
EP1806405A3 (de) Vektoren, Zellen und Verfahren zur Herstellung pyrimidiner Desoxyribonukleoside
AU5206899A (en) Uses of dna-pk
WO2000060087A3 (en) Cyclin dependent kinase inhibitor genes from plants
DE60130465D1 (de) Mutierte muskelspezifische enhancer
WO2005017176A3 (en) Methods for identifying risk of melanoma and treatments thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties